ArticleRMD open2026
Trends in prevalence and disability burden of main rheumatic and musculoskeletal diseases in France 2008-2022.
Article in RMD open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess prevalence, associated disability and pain burden of the main rheumatic and musculoskeletal diseases (RMDs): rheumatoid and non-rheumatoid inflammatory arthritis, knee, hip and other peripheral joint osteoarthritis, osteoporosis, low back and neck pain, as well as their trends over 15 years in France.
settingTwo large nationwide representative surveys conducted in France in 2008 and 2022 that similarly and comprehensively assessed chronic conditions and disabilities.
participants20 724 participants aged ≥25 years in Disability Healthcare Household Survey (2008) and 18 562 in Autonomy Survey (2022).
main outcome measuresDisability and pain profiles with 10 indicators were constructed using the International Classification of Functioning, Disability and Health framework. A multistep approach based on a conceptual model was used to estimate the prevalence and disability burden of RMDs and their trends, controlling for age, education level, obesity and comorbidities.
resultsPrevalence of knee osteoarthritis and low back pain increased by >50% between 2008 and 2022, while rheumatoid arthritis (both sexes), non-rheumatoid arthritis and neck pain (men) and hip osteoarthritis (women) increased by 25%-50%; osteoporosis remained stable. Large increases in obesity and comorbidities, massively present in RMDs, including cardiovascular and mental disorders, contributed to increasing overall disability for all RMDs. After controlling for comorbidities, the disability burden increased (notably but not exclusively with mobility activities and pain) for low back pain and knee osteoarthritis and decreased for others except rheumatoid arthritis and neck pain, which remained stable.
conclusionsPrevalence of most RMDs increased between 2008 and 2022, causing a higher disability burden, partly due to rising levels of obesity and comorbidities. These results should inform surveillance and policies for the development of RMD preventive measures given the massive increase in chronic conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.